Susquehanna Fundamental Investments’s AstraZeneca AZN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-138,056	Closed	-$16.6M	–	1435
2021 Q3	$16.6M	Buy	+138,056	New	+$16.1M	0.3%	68
2020 Q1	–	Sell	-31,000	Closed	-$3.09M	–	306
2019 Q4	$3.09M	Buy	31,000 +5,350	+21%	+$504K	0.4%	79
2019 Q3	$2.29M	Sell	25,650 -28,709	-53%	-$2.49M	0.28%	119
2019 Q2	$4.49M	Hold	54,359	–	–	0.52%	59
2019 Q1	$4.39M	Buy	54,359 +29,659	+120%	+$2.34M	0.5%	65
2018 Q4	$1.88M	Sell	24,700 -18,800	-43%	-$1.47M	0.33%	103
2018 Q3	$3.44M	Hold	43,500	–	–	0.58%	45
2018 Q2	$3.06M	Hold	43,500	–	–	0.45%	65
2018 Q1	$3.04M	Buy	+43,500	New	+$3.01M	0.36%	89

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Susquehanna Fundamental Investments's AZN Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 138,056 shares — an estimated $16.6M sold.

Susquehanna Fundamental Investments first reported a position in AZN in Q1 2018 and held it in 9 quarters. The position peaked at $16.6M in Q3 2021. 950 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Susquehanna Fundamental Investments reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 138,056 AstraZeneca shares in Q4 2021, an estimated $16.6M.
Susquehanna Fundamental Investments first reported a position in AstraZeneca in Q1 2018 and held it in 9 quarters.
Susquehanna Fundamental Investments's AstraZeneca position peaked at $16.6M in Q3 2021.
950 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.